Clearmind Medicine Inc. Amortisation Expense
Clearmind Medicine Inc. (CMND) reported Amortisation Expense of $44.41 thousand for the 12-month period ending 2024-10-31, per its 20-F filed 2025-01-22.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AmortisationExpense · last filed 2025-01-22
- Clearmind Medicine Inc. amortisation expense for the quarter ending 2023-01-31 was 18.40K CAD.
CAD
| Period end | Amortisation Expense 3 month | Amortisation Expense 12 month |
|---|---|---|
| 2023-01-31 | 18.40K CAD 6-K · filed 2023-03-17 | |
| 2022-10-31 | 82.80K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Amortisation Expense 3 month | Amortisation Expense 6 month | Amortisation Expense 9 month | Amortisation Expense 12 month |
|---|---|---|---|---|
| 2024-10-31 | $14.44K derived: 20-F 12 month − 6-K 9 month · filed 2025-01-22 | $26.61K derived: sum of 2 quarters · filed 2025-01-22 | $38.92K derived: sum of 3 quarters · filed 2025-01-22 | $44.41K 20-F · filed 2025-01-22 |
| 2024-07-31 | $12.16K derived: 6-K 9 month − 6-K 6 month · filed 2024-09-16 | $24.47K derived: sum of 2 quarters · filed 2024-09-16 | $29.96K 6-K · filed 2024-09-16 | $29.96K derived: sum of 4 quarters · filed 2024-09-16 |
| 2024-04-30 | $12.31K derived: 6-K 6 month − 6-K 3 month · filed 2024-06-13 | $17.80K 6-K · filed 2024-06-13 | $17.80K derived: sum of 3 quarters · filed 2024-06-13 | $26.40K derived: sum of 4 quarters · filed 2024-09-16 |
| 2024-01-31 | $5.49K 6-K · filed 2024-03-19 | $5.49K derived: sum of 2 quarters · filed 2024-03-19 | $14.09K derived: sum of 3 quarters · filed 2024-09-16 | $23.38K derived: sum of 4 quarters · filed 2024-09-16 |
| 2023-10-31 | $0.00 derived: 20-F/A 12 month − 6-K 9 month · filed 2024-03-18 | $8.59K derived: sum of 2 quarters · filed 2024-09-16 | $17.88K derived: sum of 3 quarters · filed 2024-09-16 | $35.38K 20-F/A · filed 2024-03-18 |
| 2023-07-31 | $8.59K derived: 6-K 9 month − 6-K 6 month · filed 2024-09-16 | $17.88K derived: sum of 2 quarters · filed 2024-09-16 | $35.38K 6-K · filed 2024-09-16 | |
| 2023-04-30 | $9.29K derived: 6-K 6 month − 6-K 3 month · filed 2024-06-13 | $26.79K 6-K · filed 2024-06-13 | ||
| 2023-01-31 | $17.50K 6-K · filed 2024-03-19 | |||
| 2022-10-31 | $60.66K 20-F/A · filed 2024-03-18 |